Gastroprotectivng Nsai Dusers Dr Bartleman Oct 2007

Loading...

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

0 comments

Post a comment

    Post a comment
    Embed Video
    Edit your comment Cancel

    Favorites, Groups & Events

    Gastroprotectivng Nsai Dusers Dr Bartleman Oct 2007 - Presentation Transcript

    1. Gastroprotective Strategies among NSAID users Anne-Pascale Bartleman October 19, 2007
    2. What exactly are NSAIDs?
    3. Why Give NSAIDs? Alleviate pain and decrease inflammation: • Arthritis • Musculoskeletal injury • Headache • Menstruation
    4. Who takes them? • 20% Canadians older than 65 had prescription! • 13 million NSAID prescriptions dispensed in Canada in 2004
    5. What are the side effects? • Non-selective inhibition COX 1 results in – Decreased protection gastric mucosa (PGE) • ulcer/irritation – Inhibition of platelet function (TXA) • increased risks bleed – Renal blood flow alterations (PGI) • Renal ischemia
    6. How Common are Side Effects? • For every dollar spent on NSAID $0.66 spent on treating side effects • 15-40% complain dyspepsia • 5-8% duodenal ulcers • 15-20% gastric ulcers • 1-2% will have GI bleed • 30-40% all GI bleeds attributable to NSAID – 50-60% of these no symptoms prior to bleed
    7. So let’s prevent this! • Misoprostol- prostoglandin E1 analogue – Protects gastric mucosa from chemical irritation • Proton Pump Inhibitors – Reduce chances of damaging gastric mucosa • Cox-2 Inhibitor – Allow COX 1 to function
    8. Misoprostol Pros • 40% GI complications when taking NSAIDs Cons • Dose related diarrhea in 20% • QID dosing Misoprostol 200 ug po QID while taking NSAID
    9. Proton Pump Inhibitors Pros • Co-prescription POST GI bleed reduces bleeds 90% Cons • ? risk of community acquired pneumonia and C Difficile diarrhea?? Omeprazole (Losec) 20 mg po OD While taking Pantoprazole (Pantoloc) 40 mg po OD NSAID Esomeprazole (Nexium) 40 mg po OD
    10. Cox 2 Inhibitor Pros • Low rates discontinuation • Decrease risk serious GI complications 60% vs traditional NSAID Cons • Increased risk of MI! • Contraindicated NYHA Class II-IV, CAD or cerebrovascular disease Celecoxib (Celebrex) 100-200 mg po OD- BID
    11. Not enough evidence they are helpful • H2 Receptor Antagonists – Ranitidine (Zantac) – Cimetidine (Tagamet) – Famotidine (Pepcid) • Sucralfate • *** Prescription of these meds with NSAID partly responsible for ineffective prevention of GI complications***
    12. Risk Factors for GI complications • History of peptic ulcer bleed • Use of anti-coagulants • Use of 2 NSAIDs (includes low does ASA) • History peptic ulcer • High NSAID dose • Age > 60 years? • Severe Illness • H. pylori infection • Use of corticosteroids
    13. How to Stratify Risk?
    14. Mr Soreknees • Mr Soreknees is a 65 year old gentleman presenting with complaints increasing knee pain. He has been told he has osteoarthritis and will need a replacement. Help him improve his daily function! • PMHx/Meds: – Hypertension (Metoprolol 12.5 mg po BID) – Atrial Fibrillation (Coumadin as directed)
    15. • What are his risk factors? – Anticoagulated – Age? • Can you suggest a treatment option? – Likely avoid COX-2 – Naprosyn (Naproxen) 250 mg po BID and – Omeprazole (Losec) 20 mg po OD
    16. In Summary…. • NSAID widely used • GI side effects common (up to 50%) • GI side effects can be significant • There are effective gastro-protective strategies • Know WHO to protect and treat prophylactically
    17. References Targownik, L.,Thomson, P. Gastroprotective Strategies among NSAID users. Canadian Family Physician. Vol 52,p 1100-1105. September 2006. Lanas, A, Ferrandez, A. Inappropriate Prevention of NSAID- Induced Gastrointestinal Events among Long-Term Users in the Elderly. Drugs and Aging. Vol 24(2) p 121-131. 2007. Canadian Agency for Drugs and Technology in Health. Preventing NSAID induced GI complications: An economic evaluation of alternative strategies in Canada. Feb 2007.

    + Flavio  GuzmánFlavio Guzmán, 5 months ago

    custom

    150 views, 0 favs, 1 embeds more stats

    More info about this document

    © All Rights Reserved

    Go to text version

    • Total Views 150
      • 115 on SlideShare
      • 35 from embeds
    • Comments 0
    • Favorites 0
    • Downloads 4
    Most viewed embeds
    • 35 views on http://pharmamotion.com.ar

    more

    All embeds
    • 35 views on http://pharmamotion.com.ar

    less

    Flagged as inappropriate Flag as inappropriate
    Flag as inappropriate

    Select your reason for flagging this presentation as inappropriate. If needed, use the feedback form to let us know more details.

    Cancel
    File a copyright complaint
    Having problems? Go to our helpdesk?

    Categories